1. Skip to navigation
  2. Skip to content
  3. Skip to sidebar

Consumer Affairs

Chronic Disease on the Rise in U.S.

Obesity, diabetes undermining the country's overall health


PhotoA new study finds that the benefits of smoking cessation programs are being offset by rising obesity and diabetes, dragging down America's overall health.  

The report from the United Health Foundationfinds that troubling increases in obesity, diabetes and children in poverty are offsetting improvements in smoking cessation, preventable hospitalizations and cardiovascular deaths.

The report finds that the country’s overall health did not improve between 2010 and 2011 – a drop from the 0.5 percent average annual rate of improvement between 2000 and 2010 and the 1.6 percent average annual rate of improvement seen in the 1990s.

State Rankings: Vermont Still on Top

For the fifth year in a row, Vermont is the nation’s healthiest state. States that showed the most substantial improvement include New York and New Jersey, both moving up six places, largely because of improvements made in smoking cessation. Idaho and Alaska showed the most downward movement. Idaho dropped 10 spots, from number nine to 19 in this year’s Rankings, and Alaska dropped five places. 

“Where people live matters. Every state can make improvements to ensure healthier quality of lives for their residents,” said Reed Tuckson, M.D., United Health Foundation board member and executive vice president and chief of medical affairs, UnitedHealth Group.

Photo“In the history of the Rankings, we have seen many examples of stakeholders coming together to improve their standing. States such as Tennessee and Maine – which made explicit efforts to improve their rankings – have shown us that improved public health is achievable but must be tackled in a concerted and aggressive way.”

This year’s Rankings, which offers a state-by-state snapshot of population health based on 23 measures, includes several positive nationwide trends:

  • Smoking cessation: 17.3 percent of the population smoked in 2011, down from 17.9 percent in 2010 – a 3.4 percent decline since 2010; a 25.4 percent decline since 2001.
  • Preventable hospitalizations: 68.2 preventable hospitalizations per 1,000 Medicare enrollees in 2011, down from 70.6 preventable hospitalizations in 2010 – a 3.4 percent decline since 2010; a 17.3 percent decline since 2001.
  • Cardiovascular deaths: 270.4 deaths per 100,000 in 2011, down from 278.2 deaths per 100,000 in 2010 – a 2.8 percent decline since 2010; a 22.2 percent decline since 2001.

These improvements were offset by troubling increases in:

  • Obesity: 27.5 percent of the adult population in 2011, up from 26.9 percent of the adult population in 2010 – a 2.2 percent increase since 2010; a 37.5 percent increase since 2001; 2011 is the first year when no state had an obesity prevalence under 20 percent.
  • Diabetes: 8.7 percent in 2011, up from 8.3 percent in 2010 – a 4.8 percent increase since 2010; a 42.6 percent increase since 2001.
  • Children in poverty: 21.5 percent in 2011, up from 20.7 percent in 2010 – a 3.9 percent increase since 2010; a 33.5 percent increase since 2001.

The fact that the country did not improve in overall health status means there was a balance between improvements and detriments across all 23 measures.

A compelling example of this stagnation is the improvement in the number of smokers being offset by worsening rates of obesity: the Rankings found that, for every person who quit smoking in 2011, another person became obese.


Share your Comments

Please enable javascript to comment on this page
Daniel Haszard (Wed, 07 Dec 2011 15:37:32 +0000): Be aware of drugs that potentiate diabetes. Eli Lilly Zyprexa Olanzapine issues linger. The use of powerful antipsychotic drugs has increased in children as young as three years old. Weight gain, increases in triglyceride levels and associated risks for diabetes and cardiovascular disease. The average weight gain (adults) over the 12 week study period was the highest for Zyprexa—17 pounds. You’d be hard pressed to gain that kind of weight sport-eating your way through the holidays.One in 145 adults died in clinical trials of those taking the antipsychotic drug Zyprexa. This was Lilly's #1 product $5 billion per year sales, moreover Lilly also make billions more on drugs that treat diabetes. --- Daniel Haszard Zyprexa activist and patient.
Quantcast